Status:
UNKNOWN
Neuropsychological and Brain Medical Imaging Study in Patients With Brain Damage
Lead Sponsor:
University Hospital, Rouen
Conditions:
Cerebrovascular Disorders
Brain Lesions
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Two groups of subjects will be constitute: (i) patients with circumscribed brain injury (including stroke, vascular malformations, tumor or circumscribed infectious lesions) or degenerative disorders ...
Eligibility Criteria
Inclusion
- age between 18 and 80 years
- french language
- effective contraception for women during the study
- informed consent
- no alcohol intake the day before the exam
- for patients only, focal cerebral lesion (stroke, malformation, tumor, inflammatory, infectious, traumatic), neonatal pathology or degenerative disease with cognitive deficit
Exclusion
- for healthy volunteers: previous neurological history (except non complicated migraine), previous psychiatric history (except depression with good evolution or anxiety with maximum one anxiolytic treatment), or severe cranial traumatism
- for patients: vigilance disorders, severe depression or anxiety.
- for both: psychotropic medication other than a hypnotic or an anxiolytic at low doses without dose modification for at least one month, severe visual or auditory impairment, patient without judicial or administrative liberty, measure of legal protection or no capable to express their consent, pregnancy or breastfeeding, contraindication for MRI, participation in another trial or former involvement in another trial within one month
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2019
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01849549
Start Date
May 1 2013
End Date
January 1 2019
Last Update
December 7 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU - Hôpitaux de Rouen
Rouen, France, 76031